MAPT and Alzheimer disease: The NLRP3 inflammasome has been shown to colocalize with neuritic plaques, and its level is substantially elevated in AD brains.5 The activation of the NLRP3 inflammasome enhances Aβ aggregation by reducing Aβ phagocytosis.5,6 However, its effect on tau pathology is not known.